| __timestamp | Amneal Pharmaceuticals, Inc. | Grifols, S.A. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 660772000 |
| Thursday, January 1, 2015 | 109679000 | 736435000 |
| Friday, January 1, 2016 | 118757000 | 775266000 |
| Sunday, January 1, 2017 | 109046000 | 860348000 |
| Monday, January 1, 2018 | 230435000 | 814775000 |
| Tuesday, January 1, 2019 | 289598000 | 942821000 |
| Wednesday, January 1, 2020 | 326727000 | 985616000 |
| Friday, January 1, 2021 | 365504000 | 1061508000 |
| Saturday, January 1, 2022 | 399700000 | 1190423000 |
| Sunday, January 1, 2023 | 429675000 | 1254234000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, operational efficiency is key to maintaining a competitive edge. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: Grifols, S.A. and Amneal Pharmaceuticals, Inc., from 2014 to 2023. Over this period, Grifols consistently outpaced Amneal in SG&A spending, with an average annual expense nearly four times higher. By 2023, Grifols' SG&A expenses surged to approximately 1.25 billion, marking a 90% increase from 2014. In contrast, Amneal's expenses grew by over 400%, reaching around 430 million. This stark contrast highlights Grifols' expansive operational scale and strategic investments. As the industry faces mounting pressures, understanding these financial dynamics offers valuable insights into each company's strategic priorities and market positioning.
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Amneal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Novo Nordisk A/S vs Amneal Pharmaceuticals, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Amgen Inc. and Amneal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Grifols, S.A.
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Grifols, S.A. vs Cytokinetics, Incorporated
Grifols, S.A. and ACADIA Pharmaceuticals Inc.: SG&A Spending Patterns Compared
Grifols, S.A. or Supernus Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and Mesoblast Limited
Grifols, S.A. vs Xencor, Inc.: SG&A Expense Trends
Amneal Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.: SG&A Expense Trends
Amneal Pharmaceuticals, Inc. and Evotec SE: SG&A Spending Patterns Compared